These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 15727649

  • 1. Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A.
    Weber A, Heger S, Sinkgraven R, Heckmann M, Elsner P, Rzany B.
    Br J Dermatol; 2005 Feb; 152(2):342-5. PubMed ID: 15727649
    [Abstract] [Full Text] [Related]

  • 2. No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis.
    Krogstad AL, Skymne A, Pegenius G, Elam M, Wallin BG.
    Br J Dermatol; 2005 Feb; 152(2):329-33. PubMed ID: 15727647
    [Abstract] [Full Text] [Related]

  • 3. The successful use of botulinum toxin for the treatment of nasal hyperhidrosis.
    Geddoa E, Balakumar AK, Paes TR.
    Int J Dermatol; 2008 Oct; 47(10):1079-80. PubMed ID: 18986362
    [Abstract] [Full Text] [Related]

  • 4. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
    Solish N, Benohanian A, Kowalski JW, Canadian Dermatology Study Group on Health-Related Quality of Life in Primary Axillary Hyperhidrosis.
    Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315
    [Abstract] [Full Text] [Related]

  • 5. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J, Simonart T.
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Botulinum toxin A for quality of life improvement in post-parotidectomy gustatory sweating (Frey's syndrome).
    Hartl DM, Julieron M, LeRidant AM, Janot F, Marandas P, Travagli JP.
    J Laryngol Otol; 2008 Oct; 122(10):1100-4. PubMed ID: 18289458
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis.
    Absar MS, Onwudike M.
    Dermatol Surg; 2008 Jun; 34(6):751-5. PubMed ID: 18318723
    [Abstract] [Full Text] [Related]

  • 12. Health-related quality of life after thoracoscopic sympathectomy for palmar hyperhidrosis.
    Kumagai K, Kawase H, Kawanishi M.
    Ann Thorac Surg; 2005 Aug; 80(2):461-6. PubMed ID: 16039186
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M, Ceballos-Baumann AO, Plewig G, Hyperhidrosis Study Group.
    N Engl J Med; 2001 Feb 15; 344(7):488-93. PubMed ID: 11172190
    [Abstract] [Full Text] [Related]

  • 17. Effect and persistency of botulinum toxin iontophoresis in the treatment of palmar hyperhidrosis.
    Davarian S, Kalantari KK, Rezasoltani A, Rahimi A.
    Australas J Dermatol; 2008 May 15; 49(2):75-9. PubMed ID: 18412805
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Axillary injection of botulinum A toxin in a patient with muscle cramps associated with severe axillary hyperhidrosis.
    Filosto M, Bertolasi L, Fincati E, Priori A, Tomelleri G, Chieregato G, Rizzuto N.
    Acta Neurol Belg; 2001 Jun 15; 101(2):121-3. PubMed ID: 11486559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.